FIB-4, APRI, and AST/ALT Ratio Compared to FibroScan for the Assessment of Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study
Background: Non-alcoholic fatty liver disease (NAFLD) is now the most prevalent chronic liver disorder globally. Liver fibrosis stage is the primary determinant of prognosis in NAFLD patients. FibroScan (transient elastography) is a validated non-invasive method for fibrosis assessment, but its availability remains lim...